Inventor
JAY COPELAND STRUM
Inventor
US
Overview
Patents· 14 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry11%
PatentTitleYear
12,565,502Substituted 1',2'-dihydro-3'h-spiro[cyclohexane-1,4'-pyrimido[5',4':4,5]pyrrolo[2,1-c] [1,2,4]triazin]-3'-ones as cyclin-dependent kinase inhibitors202612,534,472Morphic forms of trilaciclib and methods of manufacture thereof202612,497,404Morphic forms of trilaciclib and methods of manufacture thereof202512,479,855Morphic forms of trilaciclib and methods of manufacture thereof202512,364,697G1T38 superior dosage regimes202512,312,360Substituted 1',2'-dihydro-3'H-spiro[cyclohexane-1,4'-pyrimido[5',4':4,5]pyrrolo[2,1-c][1,2,4]triazin]-3'-ones as cyclin-dependent kinase inhibitors202512,285,431Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors202512,168,666Morphic forms of trilaciclib and methods of manufacture thereof202411,717,523Transient protection of normal cells during chemotherapy202311,654,148HSPC-sparing treatments for RB-positive abnormal cellular proliferation202311,643,416Substituted 1',2'-dihydro-3'H-spiro[cyclohexane-1,4'-pyrimido[5',4':4,5]pyrrolo[2,1-c][1,2,4]triazin]-3'-ones as cyclin-dependent kinase inhibitors202311,446,295Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors202211,395,821Treatment of EGFR-driven cancer with fewer side effects202211,357,779G1T38 superior dosage regimes2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to G1 THERAPEUTICS INC (8)· patent assignee history
2022–2026Based in US· patent location history
2025–2026Patents assigned to PHARMACOSMOS HOLDING AS (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| G1 THERAPEUTICS INC | 8 | 2022–2025 |
| PHARMACOSMOS HOLDING AS | 7 | 2025–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 14 | 2022–2026 |